Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P23193 (
transcription elongation factor
)
739
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TAZ
promotes growth, development and tumorigenesis by regulating the expression of target genes. However, the manner in which
TAZ
orchestrates the transcriptional responses is poorly defined. Here we demonstrate that
TAZ
forms nuclear condensates through liquid-liquid phase separation to compartmentalize its DNA-binding cofactor TEAD4, coactivators BRD4 and MED1, and the
transcription elongation factor
CDK9 for transcription.
TAZ
forms phase-separated droplets in vitro and liquid-like nuclear condensates in vivo, and this ability is negatively regulated by Hippo signalling through LATS-mediated phosphorylation and is mediated by the coiled-coil (CC) domain. Deletion of the
TAZ
CC domain or substitution with the YAP CC domain prevents the phase separation of
TAZ
and its ability to induce the expression of
TAZ
-specific target genes. Thus, we identify a mechanism of transcriptional activation by
TAZ
and demonstrate that pathway-specific transcription factors also engage the phase-separation mechanism for efficient and specific transcriptional activation.
...
PMID:Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression. 3220 19